Modalis Therapeutics Alternatives & Competitors
12 companies similar to Modalis Therapeutics — Modalis is an emerging biotech company that develops therapeutics using CRISPR b...
Companies similar to Modalis Therapeutics
Apertura Gene Therapy
Bringing the Future of Gene Therapy into Focus
New York, United States
克睿基因 Cure Genetics
Benifiting Lives with Genetic Engineering
China
Prime Medicine, Inc.
Delivering on the promise of Prime Editing
Cambridge, United States
Track all Modalis Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
AIRNA
The next generation of RNA editing therapeutics
Cambridge, United States
Synbio Technologies
Changing the world, one sequence at a time.
United States
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Parabilis Medicines
We are dedicated to creating extraordinary medicines for people affected by serious diseas...
Cambridge, United States
IconOVir Bio
Pushing the envelope: Our mission is to cure cancer and restore life to every patient ever...
San Diego, United States
Integra Therapeutics
Integra Therapeutics is a biotech company engineering the next generation of gene writing...
Barcelona, Spain
AGTC
Visionary science for life-changing cures.
Alachua, United States
Hunterian Medicine
Advancing cures for genetic diseases with innovative CRISPR delivery technology
Cambridge, United States
About Modalis Therapeutics
Modalis Therapeutics, an emerging biotech company founded in 2016, is pioneering the development of therapeutics using CRISPR-based technology. The company's core offering revolves around its proprietary CRISPR-GNDM technology, which allows for precise gene expression and histone modification without DNA cleavage, gene...
CRISPR-GNDM technology, epigenome editing, gene therapy development, genome editing solutions, therapeutic pipeline development
patients with genetic disorders, pharmaceutical companies, healthcare providers, biomedical researchers
Biotech Company, Genetic Medicines, CRISPR Technology, Epigenetic Gene Modulation, Precision Medicine, Orphan Genetic Diseases, Proprietary Technology, University Of Tokyo, Innovation, R&D Facilities, Tokyo Mothers 4883, Therapeutics Development, Intellectual Property, Protein Engineering, Transformative Therapeutics
B2B, B2B2C, Platform
Product Sales, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Modalis Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Modalis Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
